Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad738866e5950566f21f588",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Ofloxacin & Dexamethasoneone Sodium Phosphate Eye/Ear Drops",
"description": "CIPVISION ONLYAX DEXA Eye/Ear Drops is a pharmaceutical formulation containing Ofloxacin and Dexamethasone Sodium Phosphate. These ingredients perform complementary roles: Ofloxacin helps control infections caused by susceptible bacteria, while Dexamethasone Sodium Phosphate helps reduce inflammation. The combination may be prescribed for selected eye or ear conditions when both antibacterial treatment and inflammation control are clinically appropriate.\n\nIntended for ophthalmic and otic applications, CIPVISION ONLYAX DEXA should be used according to a qualified healthcare professional's instructions. The suitability of this formulation depends on the patient's diagnosis, medical history, and the approved product information.\n\nWith its defined composition and distinct brand identity, CIPVISION ONLYAX DEXA is a pharmaceutical product option for healthcare professionals, pharmacies, and medical distributors.\n\nComposition of CIPVISION ONLYAX DEXA Eye/Ear Drops\n\nCIPVISION ONLYAX DEXA contains two active pharmaceutical ingredients:\n\nOfloxacin: A fluoroquinolone antibiotic that works by interfering with bacterial enzymes required for DNA replication and repair. This action helps inhibit the growth of susceptible bacteria.\n\nDexamethasone Sodium Phosphate: A corticosteroid that suppresses inflammatory responses and helps reduce symptoms such as redness, swelling, and discomfort when steroid treatment is appropriate.\n\nThe exact strength, approved indications, and recommended dosage should always be checked on the product packaging and prescribing information.\n\nKey Features of CIPVISION ONLYAX DEXA\n\nThe formulation combines antibacterial and anti-inflammatory properties in one topical product.\n\nDual-ingredient formulation: Combines an antibiotic with a corticosteroid.\n\nAntibacterial action: Ofloxacin targets susceptible bacteria when used for an appropriate indication.\n\nInflammation control: Dexamethasone Sodium Phosphate helps manage inflammatory symptoms.\n\nTopical application: Intended for eye or ear use according to the approved product labelling.\n\nProfessional supervision: Requires appropriate clinical assessment and guidance for safe use.\n\nThe suitability of these features depends on the diagnosed condition and whether both ingredients are necessary for treatment.\n\nWhat Is CIPVISION ONLYAX DEXA Used For?\n\nCIPVISION ONLYAX DEXA may be prescribed for certain bacterial eye or ear conditions accompanied by inflammation. A healthcare professional must determine whether this combination is appropriate for the specific diagnosis.\n\nOphthalmic Applications\n\nWhen indicated by the approved product label, an Ofloxacin and Dexamethasone formulation may be used for selected bacterial eye conditions associated with inflammation.\n\nOfloxacin helps address susceptible bacterial pathogens, while Dexamethasone Sodium Phosphate helps control the inflammatory response. However, eye redness, watering, itching, and pain can result from allergies, viral infections, fungal infections, or other disorders. These conditions may require different treatments.\n\nA proper eye examination is important before using antibiotic-corticosteroid drops.\n\nOtic Applications\n\nFor selected ear conditions, an appropriate antibiotic and corticosteroid combination may be prescribed when bacterial infection and inflammation occur together.\n\nSymptoms such as ear pain, discharge, swelling, and itching can have different causes. The choice of treatment depends on the site of infection, the condition of the eardrum, and the product's approved indications.\n\nUse CIPVISION ONLYAX DEXA in the ear only when the prescribing information permits it and a healthcare professional recommends its use.\n\nHow Does CIPVISION ONLYAX DEXA Work?\n\nThe two active ingredients act through different mechanisms.\n\nOfloxacin: This antibiotic inhibits bacterial enzymes called DNA gyrase and topoisomerase IV. These enzymes are essential for bacterial DNA replication and repair. Interfering with these processes helps prevent susceptible bacteria from multiplying.\n\nDexamethasone Sodium Phosphate: This corticosteroid reduces inflammatory activity in affected tissues. It helps control inflammation and associated symptoms when corticosteroid treatment is medically appropriate.\n\nTogether, these ingredients provide antibacterial and anti-inflammatory effects in selected conditions. However, corticosteroids may mask signs of infection or worsen certain untreated infections. Therefore, this combination should only be used for an appropriate diagnosis under medical supervision.\n\nPotential Benefits of CIPVISION ONLYAX DEXA\n\nThe potential benefits depend on the patient's condition and the clinical suitability of the formulation.\n\nCombined treatment approach: Offers an antibiotic and an anti-inflammatory ingredient in one formulation.\n\nTargeted antibacterial activity: Ofloxacin acts against susceptible bacteria.\n\nInflammation management: Dexamethasone Sodium Phosphate helps reduce inflammation.\n\nLocal administration: Drops allow topical application when suitable for the diagnosed condition.\n\nSupport for prescribed treatment: May be included in a healthcare professional's treatment plan for selected eye or ear conditions.\n\nThis product is not suitable for every infection. Its effectiveness depends on the cause of the condition, bacterial susceptibility, correct administration, and adherence to the prescribed treatment.\n\nHow to Use CIPVISION ONLYAX DEXA Eye/Ear Drops\n\nUse CIPVISION ONLYAX DEXA according to your doctor's instructions and the product label.\n\nWash your hands: Clean your hands before handling the bottle or administering the drops.\n\nCheck the product: Confirm the product name, expiry date, and instructions before use.\n\nAvoid contamination: Do not allow the dropper tip to touch your eye, ear, fingers, or other surfaces.\n\nFollow the prescribed dose: Use only the number of drops and the frequency recommended by your healthcare professional.\n\nComplete the prescribed course: Do not stop, extend, or repeat treatment without medical advice.\n\nAvoid sharing: Never share the bottle with another person, as this can spread infection.\n\nStore correctly: Follow the storage and after-opening instructions printed on the packaging.\n\nFor eye administration, ask your healthcare professional about contact lens precautions. For ear administration, seek advice before use if you have had ear surgery, have ear tubes, or may have a perforated eardrum.\n\nPrecautions and Safety Information\n\nCIPVISION ONLYAX DEXA should be used only when clinically indicated. Its antibiotic and corticosteroid components may not be appropriate for every patient or type of infection.\n\nProlonged use: Extended or inappropriate corticosteroid use may increase eye pressure, contribute to glaucoma or cataracts, and delay tissue healing.\n\nInfection risks: Corticosteroids may mask symptoms or worsen certain viral, fungal, or untreated infections.\n\nAllergies: Inform your healthcare professional about any previous reaction to Ofloxacin, Dexamethasone, or related ingredients.\n\nExisting conditions: Disclose any history of glaucoma, eye disease, ear problems, or ear surgery before treatment.\n\nOther medicines: Tell your doctor about other prescription medicines and eye or ear preparations you are using.\n\nPregnancy and breastfeeding: Seek medical advice before using the product during pregnancy or while breastfeeding.\n\nWorsening symptoms: Obtain prompt medical assessment if symptoms persist, worsen, or return after treatment.\n\nSeek urgent medical attention for severe eye pain, sudden changes in vision, significant hearing changes, or other serious symptoms.\n\nDo not use the product after its expiry date. Follow the packaging instructions for storage and disposal after opening.\n\nWhy Is CIPVISION ONLYAX DEXA Relevant to Pharmaceutical Product Portfolios?\n\nCIPVISION ONLYAX DEXA combines two established pharmaceutical ingredients in a topical formulation intended for selected conditions involving bacterial infection and inflammation. Its defined composition and identifiable brand make it relevant to pharmaceutical catalogues and product information resources.\n\nFor pharmacies, distributors, healthcare professionals, and pharmaceutical websites, clear product information helps communicate the formulation's intended use, precautions, and administration requirements. Accurate product descriptions should always reflect the approved label rather than imply that the formulation is suitable for every eye or ear complaint.\n\nConclusion\n\nCIPVISION ONLYAX DEXA Eye/Ear Drops contains Ofloxacin and Dexamethasone Sodium Phosphate, combining antibacterial activity with anti-inflammatory action. It may be prescribed for selected eye or ear conditions when both components are clinically appropriate.\n\nUnderstanding the composition, intended applications, administration precautions, and potential risks supports responsible use. Always consult a qualified healthcare professional and refer to the approved product packaging for the exact strength, indications, contraindications, and directions for use.\n\nFrequently Asked Questions (FAQs)\n\n1. What is CIPVISION ONLYAX DEXA Eye/Ear Drops?\n\nCIPVISION ONLYAX DEXA is a pharmaceutical formulation containing Ofloxacin, an antibiotic, and Dexamethasone Sodium Phosphate, a corticosteroid. It is intended for selected conditions as directed by a healthcare professional.\n\n2. What is the composition of CIPVISION ONLYAX DEXA?\n\nThe stated active ingredients are Ofloxacin and Dexamethasone Sodium Phosphate. Refer to the product packaging to confirm their exact strengths and the approved formulation details.\n\n3. What is CIPVISION ONLYAX DEXA used for?\n\nIt may be prescribed for certain bacterial eye or ear conditions associated with inflammation when an antibiotic-corticosteroid combination is appropriate.\n\n4. Can CIPVISION ONLYAX DEXA be used without medical advice?\n\nNo. Medical guidance is important because the corticosteroid component may worsen certain infections or be unsuitable for particular eye and ear conditions.\n\n5. How should CIPVISION ONLYAX DEXA be stored?\n\nFollow the storage instructions printed on the product packaging. Keep the bottle tightly closed as directed, protect it from unsuitable storage conditions, and keep it out of children's reach.\n\n6. Can CIPVISION ONLYAX DEXA be used for every type of eye or ear infection?\n\nNo. Different infections and inflammatory conditions require different treatments. A healthcare professional should identify the cause of the symptoms and confirm whether this formulation is appropriate.",
"price": 50.0,
"discountamount": 15.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2502,
"imageuri": "https://productimages.withfloats.com/actual/6ad73887063777c0e22d5809.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad73887063777c0e22d5809.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T09:46:46.02Z",
"updatedon": "2026-10-20T09:46:46.02Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//ofloxacin-dexamethasoneone-sodium-phosphate-eye-ear-drops/2502",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION ONLYAX DEXA",
"category": "Opthalmology Range",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a8c3838c90065ecdc86c757",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Semaglutide Injection 4mg",
"description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.",
"price": 6600.0,
"discountamount": 1980.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2497,
"imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-24T12:25:28.659Z",
"updatedon": "2026-08-24T12:25:28.659Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-4mg/2497",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "SAMIGLUTIDE 4 MG",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a5dede90a28dfffb7c76516",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Tobramycin Ophthalmic Ointment USP",
"description": "CIPVISION MYCOAZITHER is an ophthalmic antibiotic ointment formulated with Azithromycin 1% w/w, manufactured by Steris Healthcare Pvt. Ltd. It is prescribed by eye specialists to treat bacterial infections of the eye caused by organisms sensitive to Azithromycin. As a macrolide-class antibiotic, it works by blocking the protein-building machinery bacteria rely on to multiply, halting the spread of infection at the source.\n\nBacterial eye infections often bring redness, swelling, watering, crusty eyelids, and general discomfort. Left unchecked, they can progress and interfere with everyday eye function. CIPVISION MYCOAZITHER is applied directly to the affected eye, concentrating the antibiotic exactly where it's needed to clear the infection and ease these symptoms.\n\nThis ointment is meant for use strictly under an ophthalmologist's guidance. It has no role in treating infections caused by viruses or fungi.\n\nComposition\n\nEvery gram of the ointment contains:\n\nAzithromycin Eye Ointment 1% w/w\n\nWhat Is CIPVISION MYCOAZITHER Prescribed For?\n\nDoctors recommend CIPVISION MYCOAZITHER for bacterial eye conditions such as:\n\nBacterial conjunctivitis (commonly called pink eye)\nBacterial infections of the eyelid margins\nSurface-level bacterial infections of the eye\nBacterial infections following eye surgery, where advised\nOther ocular bacterial infections identified by an eye care specialist\n\nAn ophthalmologist is best placed to confirm whether this ointment suits your particular eye condition.\n\nMechanism of Action\n\nAzithromycin is a macrolide antibiotic. It attaches to the 50S ribosomal subunit inside susceptible bacterial cells, disrupting their ability to synthesize proteins. Without this protein-building process, the bacteria can't grow or reproduce, giving the immune system the opening it needs to clear the infection.\n\nBecause it's delivered topically to the eye, the ointment achieves a strong local concentration right at the infection site, while limiting how much medicine enters the bloodstream.\n\nBenefits of Using CIPVISION MYCOAZITHER\n\nUsed correctly under medical supervision, this ointment may:\n\nClear bacterial eye infections caused by sensitive organisms\nCalm redness and swelling linked to the infection\nEase eye irritation and discomfort\nCurb further bacterial growth\nAid recovery of infected eye tissue\nSpeed healing from bacterial conjunctivitis\nLower the chance of the infection spreading further\nHow to Apply the Ointment Correctly\n\nFollow these steps for effective application:\n\nWash your hands well before starting.\nTilt your head back a little.\nPull the lower eyelid down gently to form a small pocket.\nSqueeze a thin line of ointment into that pocket, keeping the tube tip away from your eye and skin.\nShut your eyes softly for a minute or two so the ointment spreads evenly.\nBlot away any extra ointment with a clean tissue.\nWash your hands again once done.\n\nStick to your doctor's prescribed schedule and finish the entire course, even if your symptoms clear up sooner than expected.\n\nDosage Guidance\n\nUse CIPVISION MYCOAZITHER strictly as your ophthalmologist prescribes. Don't adjust the amount, frequency, or duration on your own.\n\nPossible Side Effects\n\nSide effects vary from person to person and aren't guaranteed to occur.\n\nCommonly reported effects:\n\nBrief blurring of vision right after application\nMild stinging or burning\nEye irritation\nExcess tearing\nSlight itching\nShort-lived discomfort\n\nSeek urgent medical care if you notice:\n\nIntense eye pain\nSudden vision changes\nSwelling around the face or eyelids\nTrouble breathing\nSigns of a severe allergic reaction\nPrecautions Before Use\n\nLet your doctor know if any of these apply to you:\n\nHistory of allergy to Azithromycin, erythromycin, or related macrolide antibiotics\nYou wear contact lenses\nYou have a serious eye injury\nYou currently have a viral or fungal eye infection\nYou're pregnant or breastfeeding\nYou're using any other eye drops or ointments\n\nTake care not to let the tube's tip touch your eye, eyelid, or any other surface — this helps avoid contaminating the product.\n\nIs It Safe to Wear Contact Lenses?\n\nIt's best to skip contact lenses while an eye infection is active, unless your ophthalmologist tells you otherwise.\n\nStorage Instructions\nKeep below 25°C.\nShield the tube from heat and direct sunlight.\nClose the cap firmly after each use.\nStore out of children's reach.\nDiscard once the expiry date has passed.\nWhy Choose CIPVISION MYCOAZITHER from Steris Healthcare Pvt. Ltd.?\n\nSteris Healthcare Pvt. Ltd. manufactures CIPVISION MYCOAZITHER under strict quality controls to ensure dependable ophthalmic treatment. The 1% w/w Azithromycin formulation targets the infection directly at its source, supporting effective bacterial eye-infection management when used exactly as your doctor prescribes.\n\nFor the best outcome, follow your ophthalmologist's instructions precisely and keep any recommended follow-up visits.\n\nDisclaimer: Use this medicine only under a qualified healthcare professional's guidance. It is meant for bacterial eye infections and should not be used for viral, fungal, or other non-bacterial conditions unless a doctor specifically advises it.\n\nFrequently Asked Questions\n\nWhat does CIPVISION MYCOAZITHER treat? It treats bacterial eye infections caused by organisms sensitive to Azithromycin, under an eye specialist's supervision.\n\nHow does Azithromycin Eye Ointment act on the infection? It blocks bacteria from making the proteins they need to survive and multiply, letting the infection resolve.\n\nWill it work on viral conjunctivitis? No — it only targets susceptible bacterial infections and isn't meant for viral or fungal eye infections unless specifically prescribed.\n\nCan I stop applying it once my eye looks better? No. Finish the full course your doctor prescribed to make sure the infection is fully cleared and doesn't come back.\n\nCan I combine it with other eye medicines? Only if your doctor approves. If you're using more than one eye medication, space out the applications as recommended.",
"price": 120.0,
"discountamount": 36.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2475,
"imageuri": "https://productimages.withfloats.com/actual/6a5dedeb124cadcb9465dcec.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a5dedeb124cadcb9465dcec.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-20T09:44:09.629Z",
"updatedon": "2026-07-20T09:44:09.629Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//tobramycin-ophthalmic-ointment-usp/2475",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION TIBOCLORICUS EYE OINTMENT",
"category": "Opthalmology Range",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a5de8a70a28dfffb7c764ed",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Azithromycin Eye Ointment 1% w/w",
"description": "CIPVISION MYCOAZITHER is an ophthalmic antibiotic ointment formulated with Azithromycin 1% w/w, manufactured by Steris Healthcare Pvt. Ltd. It is prescribed by eye specialists to treat bacterial infections of the eye caused by organisms sensitive to Azithromycin. As a macrolide-class antibiotic, it works by blocking the protein-building machinery bacteria rely on to multiply, halting the spread of infection at the source.\n\nBacterial eye infections often bring redness, swelling, watering, crusty eyelids, and general discomfort. Left unchecked, they can progress and interfere with everyday eye function. CIPVISION MYCOAZITHER is applied directly to the affected eye, concentrating the antibiotic exactly where it's needed to clear the infection and ease these symptoms.\n\nThis ointment is meant for use strictly under an ophthalmologist's guidance. It has no role in treating infections caused by viruses or fungi.\n\nComposition\n\nEvery gram of the ointment contains:\n\nAzithromycin Eye Ointment 1% w/w\n\nWhat Is CIPVISION MYCOAZITHER Prescribed For?\n\nDoctors recommend CIPVISION MYCOAZITHER for bacterial eye conditions such as:\n\nBacterial conjunctivitis (commonly called pink eye)\nBacterial infections of the eyelid margins\nSurface-level bacterial infections of the eye\nBacterial infections following eye surgery, where advised\nOther ocular bacterial infections identified by an eye care specialist\n\nAn ophthalmologist is best placed to confirm whether this ointment suits your particular eye condition.\n\nMechanism of Action\n\nAzithromycin is a macrolide antibiotic. It attaches to the 50S ribosomal subunit inside susceptible bacterial cells, disrupting their ability to synthesize proteins. Without this protein-building process, the bacteria can't grow or reproduce, giving the immune system the opening it needs to clear the infection.\n\nBecause it's delivered topically to the eye, the ointment achieves a strong local concentration right at the infection site, while limiting how much medicine enters the bloodstream.\n\nBenefits of Using CIPVISION MYCOAZITHER\n\nUsed correctly under medical supervision, this ointment may:\n\nClear bacterial eye infections caused by sensitive organisms\nCalm redness and swelling linked to the infection\nEase eye irritation and discomfort\nCurb further bacterial growth\nAid recovery of infected eye tissue\nSpeed healing from bacterial conjunctivitis\nLower the chance of the infection spreading further\nHow to Apply the Ointment Correctly\n\nFollow these steps for effective application:\n\nWash your hands well before starting.\nTilt your head back a little.\nPull the lower eyelid down gently to form a small pocket.\nSqueeze a thin line of ointment into that pocket, keeping the tube tip away from your eye and skin.\nShut your eyes softly for a minute or two so the ointment spreads evenly.\nBlot away any extra ointment with a clean tissue.\nWash your hands again once done.\n\nStick to your doctor's prescribed schedule and finish the entire course, even if your symptoms clear up sooner than expected.\n\nDosage Guidance\n\nUse CIPVISION MYCOAZITHER strictly as your ophthalmologist prescribes. Don't adjust the amount, frequency, or duration on your own.\n\nPossible Side Effects\n\nSide effects vary from person to person and aren't guaranteed to occur.\n\nCommonly reported effects:\n\nBrief blurring of vision right after application\nMild stinging or burning\nEye irritation\nExcess tearing\nSlight itching\nShort-lived discomfort\n\nSeek urgent medical care if you notice:\n\nIntense eye pain\nSudden vision changes\nSwelling around the face or eyelids\nTrouble breathing\nSigns of a severe allergic reaction\nPrecautions Before Use\n\nLet your doctor know if any of these apply to you:\n\nHistory of allergy to Azithromycin, erythromycin, or related macrolide antibiotics\nYou wear contact lenses\nYou have a serious eye injury\nYou currently have a viral or fungal eye infection\nYou're pregnant or breastfeeding\nYou're using any other eye drops or ointments\n\nTake care not to let the tube's tip touch your eye, eyelid, or any other surface — this helps avoid contaminating the product.\n\nIs It Safe to Wear Contact Lenses?\n\nIt's best to skip contact lenses while an eye infection is active, unless your ophthalmologist tells you otherwise.\n\nStorage Instructions\nKeep below 25°C.\nShield the tube from heat and direct sunlight.\nClose the cap firmly after each use.\nStore out of children's reach.\nDiscard once the expiry date has passed.\nWhy Choose CIPVISION MYCOAZITHER from Steris Healthcare Pvt. Ltd.?\n\nSteris Healthcare Pvt. Ltd. manufactures CIPVISION MYCOAZITHER under strict quality controls to ensure dependable ophthalmic treatment. The 1% w/w Azithromycin formulation targets the infection directly at its source, supporting effective bacterial eye-infection management when used exactly as your doctor prescribes.\n\nFor the best outcome, follow your ophthalmologist's instructions precisely and keep any recommended follow-up visits.\n\nDisclaimer: Use this medicine only under a qualified healthcare professional's guidance. It is meant for bacterial eye infections and should not be used for viral, fungal, or other non-bacterial conditions unless a doctor specifically advises it.\n\nFrequently Asked Questions\n\nWhat does CIPVISION MYCOAZITHER treat? It treats bacterial eye infections caused by organisms sensitive to Azithromycin, under an eye specialist's supervision.\n\nHow does Azithromycin Eye Ointment act on the infection? It blocks bacteria from making the proteins they need to survive and multiply, letting the infection resolve.\n\nWill it work on viral conjunctivitis? No — it only targets susceptible bacterial infections and isn't meant for viral or fungal eye infections unless specifically prescribed.\n\nCan I stop applying it once my eye looks better? No. Finish the full course your doctor prescribed to make sure the infection is fully cleared and doesn't come back.\n\nCan I combine it with other eye medicines? Only if your doctor approves. If you're using more than one eye medication, space out the applications as recommended.",
"price": 110.0,
"discountamount": 33.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2474,
"imageuri": "https://productimages.withfloats.com/actual/6a5de8a9771761e1cf709714.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a5de8a9771761e1cf709714.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-20T09:21:43.276Z",
"updatedon": "2026-07-20T09:21:43.276Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//azithromycin-eye-ointment-1-w-w/2474",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION MYCOAZITHER",
"category": "Opthalmology Range",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a50a78a75263abd944f583a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Loteprednol Etabonate Ophthalmic Suspension",
"description": "Loteprednol etabonate ophthalmic suspension is a prescription corticosteroid eye drop used to treat steroid-responsive inflammatory conditions of the eye, including post-surgical inflammation, allergic conjunctivitis, and certain forms of anterior uveitis. What sets loteprednol apart from older ophthalmic steroids is its “ester-based” chemical structure, which is designed to break down into inactive components after acting on eye tissue — giving it a comparatively lower risk of raising intraocular pressure (IOP) than traditional steroids like prednisolone or dexamethasone, while still delivering effective anti-inflammatory action. The typical dose is one to two drops in the affected eye, four times daily, or as directed, usually for a short, defined course rather than indefinite use. Common side effects include burning, stinging, and blurred vision, while prolonged or unsupervised use can still carry steroid-related risks such as elevated eye pressure. It is a Schedule H prescription-only medicine in India.\n\nWhat Is Loteprednol Etabonate Ophthalmic Suspension?\nLoteprednol etabonate ophthalmic suspension is a topical corticosteroid formulated specifically for use in the eye. It belongs to a category sometimes referred to as “site-specific” or “soft” steroids — a design approach where the drug is engineered to be highly active at the site of application (the eye) but rapidly metabolized into inactive by-products once it has acted, reducing the potential for the cumulative steroid-related side effects seen with older ophthalmic corticosteroids.\nThis suspension is commonly prescribed for:\n\nManaging inflammation following eye surgery, such as cataract surgery\nTreating allergic conjunctivitis, including seasonal allergic conjunctivitis\nCertain anterior segment inflammatory conditions, such as uveitis, under specialist supervision\nGiant papillary conjunctivitis and other steroid-responsive ocular surface conditions\n\nBecause of its comparatively favorable IOP profile, loteprednol is often considered by ophthalmologists for patients who need effective anti-inflammatory therapy but may be at higher risk from more potent steroids — though it is important to note that no ophthalmic steroid is entirely free of IOP-related risk, and monitoring remains necessary.\n\nHow Does Loteprednol Etabonate Work? (Mechanism of Action)\n\nCorticosteroid receptor binding – Loteprednol etabonate binds to glucocorticoid receptors within ocular tissue, initiating anti-inflammatory gene expression changes.\nSuppression of inflammatory mediators – This binding reduces the production of key inflammatory substances, including prostaglandins and cytokines, that drive redness, swelling, and discomfort.\nReduced vascular permeability – By calming the inflammatory cascade, the drug helps reduce leakage of fluid and inflammatory cells into ocular tissue, easing swelling.\nEster-based metabolism – Unlike ketone-based steroids, loteprednol's ester structure allows ocular esterases to break it down into inactive metabolites after it exerts its effect, which is thought to underlie its comparatively lower propensity to raise intraocular pressure.\nLocalized anti-inflammatory effect – The net result is effective control of ocular surface and anterior segment inflammation with a more favorable safety profile than some older steroid formulations, when used for the intended short duration.\n\n\nClinical Indications\nIndicationDetailsPost-operative ocular inflammationCommon after cataract and other intraocular surgeriesAllergic conjunctivitisIncluding seasonal allergic conjunctivitisGiant papillary conjunctivitisOften associated with contact lens wearAnterior uveitisUnder specialist supervisionOther steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segmentAs directed by an ophthalmologist\nNot indicated for: viral (e.g., herpes simplex), fungal, or mycobacterial eye infections, where corticosteroid use can worsen the underlying condition.\n\nDosage & Administration\nParameterRecommendationStandard dose1–2 drops in the affected eye(s), typically 4 times dailyPost-surgical regimenOften started at higher frequency and tapered per surgeon's protocolShake before useYes — this is a suspension; shake well before each applicationDurationShort, defined course as prescribed; not intended for indefinite useTaperingGradual reduction recommended rather than abrupt discontinuation after extended useContact lensesRemove before instillation; reinsert only per your doctor's adviceMissed doseApply as soon as remembered; do not double the next dose\nImportant: Even with its comparatively favorable safety profile, loteprednol should be used strictly for the duration prescribed. Extended, unsupervised use is not recommended.\n\nKey Benefits\n\nEffective anti-inflammatory action for a range of steroid-responsive ocular conditions\nEster-based design associated with a comparatively lower risk of raising intraocular pressure than some older ophthalmic steroids\nUseful for patients needing steroid therapy who may be more sensitive to IOP elevation, under appropriate monitoring\nSuitable for both post-surgical inflammation control and allergic conjunctivitis management\nAvailable in a suspension formulation designed for good ocular surface contact\nOften used as part of a short, defined treatment course, reducing exposure duration compared to continuous long-term steroid regimens\n\n\nPrecautions\n\nUse strictly under ophthalmologist supervision — this is not an over-the-counter product\nNot suitable for viral, fungal, or mycobacterial eye infections\nEven with its favorable profile, prolonged use can still raise intraocular pressure in susceptible individuals — periodic IOP monitoring is recommended\nExtended use may increase the risk of cataract formation, as with other ophthalmic steroids\nMay mask signs of infection or delay wound healing if used inappropriately\nInform your doctor of any history of glaucoma, herpes eye infection, or corneal thinning before starting\nShake the suspension well before each use for accurate dosing\nAvoid touching the dropper tip to the eye or any surface\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nBurning or stinging sensation on instillation\nBlurred vision immediately after application\nEye discomfort or a foreign-body sensation\nMild eye redness\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nElevated intraocular pressure (comparatively less frequent than with older steroids, but still possible)\nDelayed wound healing\nSigns of secondary or masked ocular infection\nCataract progression with prolonged use\nAllergic reaction (eyelid swelling, itching, rash)\n\nDiscontinue and consult your ophthalmologist promptly if any serious symptom develops.\n\nComparison: Loteprednol vs. Other Ophthalmic Corticosteroids\nTreatmentClassIOP Risk ProfileBest Suited ForLoteprednol etabonate suspensionEster-based (“soft”) corticosteroidComparatively lowerPatients needing effective anti-inflammatory action with reduced IOP concernPrednisolone acetateKetone-based corticosteroidHigher with prolonged useRobust anti-inflammatory action; requires closer IOP monitoringDexamethasoneKetone-based corticosteroidHigher, potent effectSevere inflammatory conditions; typically shorter coursesFluorometholoneKetone-based corticosteroidModerateMild to moderate inflammation with somewhat reduced IOP risk\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueReported incidence of clinically significant IOP elevation with short-course loteprednol use[Placeholder – insert verified clinical trial statistic]Comparative IOP-elevation rate vs. prednisolone acetate in controlled studies[Placeholder – insert verified reference]Typical duration of post-operative loteprednol therapy[Placeholder – insert reference range]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Loteprednol Etabonate Ophthalmic Suspension\nThe price of loteprednol etabonate ophthalmic suspension varies depending on brand, pack size, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nLoteprednol etabonate ophthalmic suspension offers a valuable option for managing steroid-responsive ocular inflammation — from post-surgical recovery to allergic conjunctivitis — with a design intended to reduce the intraocular pressure risks historically associated with ophthalmic corticosteroids. While its ester-based structure gives it a comparatively favorable safety profile, it remains a steroid, and prolonged or unsupervised use can still carry risks such as elevated eye pressure, cataract progression, and delayed healing. For this reason, loteprednol should always be used for the specific duration prescribed, with appropriate tapering and regular ophthalmic follow-up, rather than as a long-term, self-managed therapy.\n\nFrequently Asked Questions\n\n1. What is loteprednol etabonate ophthalmic suspension used for?\nIt is used to treat steroid-responsive eye inflammation, including inflammation after eye surgery, allergic conjunctivitis, and certain anterior segment inflammatory conditions such as uveitis, under an ophthalmologist's guidance.\n\n2. Is loteprednol a steroid?\nYes, loteprednol etabonate is a corticosteroid. It is specifically designed with an ester-based structure intended to reduce the risk of raising intraocular pressure compared to some older ophthalmic steroids, though it still requires medical supervision.\n\n3. How long can I use loteprednol eye drops?\nLoteprednol is typically prescribed for a short, defined course as determined by your ophthalmologist, often with a tapering schedule. It is not intended for indefinite, unsupervised long-term use.\n\n4. Does loteprednol raise eye pressure?\nLoteprednol has a comparatively lower risk of raising intraocular pressure than some older ophthalmic steroids due to its ester-based design, but it can still cause elevated eye pressure in susceptible individuals, especially with prolonged use, so periodic monitoring is recommended.\n\n5. Can loteprednol cause cataracts?\nProlonged use of any ophthalmic corticosteroid, including loteprednol, can increase the risk of cataract formation, particularly posterior subcapsular cataracts, which is why short, supervised courses are recommended.\n\n6. How is loteprednol different from prednisolone acetate?\nLoteprednol has an ester-based chemical structure designed to break down into inactive components after acting on the eye, which is associated with a lower risk of raising intraocular pressure compared to prednisolone acetate, a ketone-based steroid with a higher IOP-elevation potential.\n\n7. Can loteprednol be used for allergic conjunctivitis?\nYes, loteprednol etabonate ophthalmic suspension is commonly used to manage allergic conjunctivitis, including seasonal allergic conjunctivitis, especially when symptoms are significant or not controlled by other treatments.\n\n8. Is loteprednol safe after cataract surgery?\nYes, loteprednol is frequently prescribed to manage post-operative inflammation following cataract surgery, typically as part of a tapering regimen directed by the operating ophthalmologist.\n\n9. Can loteprednol be used for viral eye infections?\nNo, loteprednol and other corticosteroids are not appropriate for viral eye infections such as herpes simplex keratitis, as steroids can worsen these conditions if used inappropriately.\n\n10. What are the common side effects of loteprednol eye drops?\nCommon side effects include burning or stinging upon application, temporary blurred vision, mild eye redness, and eye discomfort. These are usually mild and resolve quickly.\n11. Does loteprednol need to be shaken before use?\nYes, since it is a suspension, the bottle should be shaken well before each use to ensure the medication is evenly distributed.\n\n12. Can loteprednol be stopped suddenly?\nStopping abruptly, especially after extended use, is generally not recommended. A gradual tapering schedule, as advised by your ophthalmologist, helps prevent rebound inflammation.\n\n13. Is loteprednol safe for long-term daily use?\nNo, loteprednol is generally intended for short, supervised courses rather than continuous long-term daily use, due to steroid-related risks with prolonged exposure.\n\n14. Can contact lenses be worn while using loteprednol?\nIt's generally recommended to remove contact lenses before applying loteprednol and reinsert them only after the interval advised by your doctor.\n\n15. Who should avoid using loteprednol eye drops?\nPatients with active untreated viral, fungal, or mycobacterial eye infections, or known hypersensitivity to the medication, should avoid loteprednol unless specifically directed otherwise by their ophthalmologist.\n\n16. Can loteprednol be used in children?\nUse in children should only occur under the direct guidance and prescription of a pediatric ophthalmologist, based on individual clinical assessment.\n17. Does loteprednol cause blurred vision?\nTemporary blurred vision can occur immediately after instillation in some patients and usually resolves quickly. Persistent blurred vision should be reported to your doctor.",
"price": 150.0,
"discountamount": 45.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2471,
"imageuri": "https://productimages.withfloats.com/actual/6a50a78cd95cad00a915a6d8.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a50a78cd95cad00a915a6d8.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-10T08:04:26.663Z",
"updatedon": "2026-07-10T08:04:26.663Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//loteprednol-etabonate-ophthalmic-suspension/2471",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION LOPEDIUM 0.5%",
"category": "Opthalmology Range",
"tags": [
"Loteprednol Etabonate Ophthalmic Suspension",
"loteprednol etabonate ophthalmic suspension uses",
"loteprednol etabonate ophthalmic suspension uses in hindi",
"loteprednol etabonate ophthalmic suspension in hindi",
"loteprednol etabonate ophthalmic suspension eye drops uses",
"loteprednol etabonate ophthalmic suspension eye drops",
"loteprednol etabonate ophthalmic suspension use"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a509bf6f44be736283180cf",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "gatifloxacin & prednisolone acetate ophthalmic suspension",
"description": "Gatifloxacin and prednisolone acetate ophthalmic suspension is a prescription combination eye medicine that pairs a fourth-generation fluoroquinolone antibiotic (gatifloxacin) with a corticosteroid (prednisolone acetate) in a single formulation. It is used to treat steroid-responsive ocular inflammation where there is also a risk of, or existing, bacterial eye infection — most commonly after cataract or other ocular surgery, and in certain inflammatory eye conditions requiring both anti-infective and anti-inflammatory action together. Gatifloxacin fights the bacteria, while prednisolone acetate reduces inflammation, redness, and swelling. This combination is not the same as a plain antibiotic drop — because it contains a steroid, it requires closer monitoring, a defined tapering schedule, and should never be self-prescribed or used beyond the duration your ophthalmologist recommends. It is a Schedule H prescription-only medicine in India, commonly marketed under brand names such as Gatiquin P.\n\nWhat Is Gatifloxacin and Prednisolone Acetate Ophthalmic Suspension?\nGatifloxacin and prednisolone acetate ophthalmic suspension is a fixed-dose combination eye drop that brings together two distinct classes of medication in one bottle:\n\nGatifloxacin — a fourth-generation fluoroquinolone antibiotic effective against a broad range of gram-positive and gram-negative bacteria commonly implicated in ocular infections.\nPrednisolone acetate — a corticosteroid that suppresses inflammation, swelling, and associated redness or discomfort in the eye.\n\nThis combination is typically prescribed when a clinician determines that an eye condition involves both active or potential bacterial infection and significant inflammation — a situation where using either drug alone would be insufficient. The most frequent use case is post-operative care following ocular surgery, such as cataract extraction, where inflammation control speeds recovery while the antibiotic component guards against surgical-site infection.\nA commonly recognized branded version of this combination in the Indian market is Gatiquin P, and patients often search specifically for this brand name alongside the generic combination name.\n\nHow Does This Combination Work? (Mechanism of Action)\n\nAntibacterial action (Gatifloxacin) – Gatifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes bacteria need to replicate their DNA, resulting in bactericidal activity against susceptible organisms.\nAnti-inflammatory action (Prednisolone acetate) – Prednisolone acetate suppresses the inflammatory cascade by inhibiting phospholipase A2 and reducing the release of inflammatory mediators, which decreases swelling, redness, and discomfort.\nCombined surgical/inflammatory coverage – Together, the two components address both the infective and inflammatory components of a single ocular condition, which is particularly useful in the immediate post-surgical period when both risks are elevated simultaneously.\nLocalized ocular delivery – As a topical suspension, the combination acts directly at the site of application, minimizing systemic absorption compared to oral antibiotics or steroids.\n\n\nClinical Indications\nIndicationDetailsPost-operative inflammation with infection riskMost common use — following cataract surgery or other intraocular proceduresSteroid-responsive inflammatory ocular conditionsWhere a bacterial infection is present or risk is significantChronic anterior uveitis with secondary infection riskUsed under specialist supervisionBlepharoconjunctivitis with inflammatory componentWhen combined anti-infective and anti-inflammatory action is clinically indicated\nNot indicated for: viral eye infections (e.g., herpes simplex keratitis), fungal eye infections, mycobacterial infections, or uncomplicated bacterial conjunctivitis without an inflammatory component — a steroid is not appropriate in these settings.\n\nDosage & Administration\nParameterRecommendationStandard dose1–2 drops in the affected eye, typically 4 times daily, or as directedPost-surgical regimenOften started with a higher frequency and gradually tapered per surgeon's protocolShake before useYes — this is a suspension; shake well before each applicationDurationDetermined by your ophthalmologist; steroid-containing drops are not for indefinite useTaperingMust be tapered gradually rather than stopped abruptly, especially after prolonged useContact lensesAvoid wearing contact lenses during treatment unless your doctor advises otherwiseMissed doseApply as soon as remembered; do not double the next dose\nImportant: Never extend use beyond the prescribed duration or restart the medication without consulting your ophthalmologist, as prolonged steroid exposure carries specific ocular risks (see Precautions below).\n\nKey Benefits\n\nProvides dual-action therapy — infection control and inflammation control — in a single formulation\nReduces the need for two separate eye drop regimens after surgery, simplifying the treatment schedule\nSpeeds resolution of post-surgical redness, swelling, and discomfort while covering infection risk\nBroad-spectrum antibacterial coverage from a fourth-generation fluoroquinolone\nCommonly trusted and prescribed by ophthalmic surgeons as part of standard post-operative protocols\nAvailable in a suspension formulation designed for effective ocular surface contact time\n\n\nPrecautions\n\nUse strictly under ophthalmologist supervision — this is not an over-the-counter product\nNot suitable for viral, fungal, or mycobacterial eye infections\nLong-term or unsupervised steroid use can raise intraocular pressure (IOP) and increase glaucoma risk\nProlonged use may increase the risk of posterior subcapsular cataract formation\nSteroid component may mask signs of a worsening infection or delay wound healing if misused\nRegular monitoring of intraocular pressure is recommended with extended use\nInform your doctor of any history of glaucoma, herpes eye infection, or corneal thinning before starting\nShake the suspension well before each use for accurate dosing\nAvoid touching the dropper tip to the eye or any surface\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nTransient burning or stinging on instillation\nBlurred vision immediately after application\nEye discomfort or foreign-body sensation\nMild eye redness\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nIncreased intraocular pressure / glaucoma symptoms (eye pain, halos around lights)\nDelayed wound healing at a surgical site\nSecondary or masked ocular infection\nSigns of cataract progression with prolonged use\nCorneal or scleral thinning (rare, with extended steroid exposure)\nAllergic reaction (eyelid swelling, itching, rash)\n\nDiscontinue and consult your ophthalmologist immediately if any serious symptom develops.\n\nComparison: Combination vs. Standalone Therapies\nTreatmentCompositionBest Suited ForKey ConsiderationGatifloxacin + Prednisolone acetate suspensionAntibiotic + steroidPost-surgical care; infection + inflammation togetherRequires tapering; steroid monitoring neededGatifloxacin eye drops (alone)Antibiotic onlyUncomplicated bacterial conjunctivitis/keratitisNo steroid-related risk, but no anti-inflammatory actionPrednisolone acetate eye drops (alone)Steroid onlyNon-infectious inflammatory conditions (e.g., uveitis)Not appropriate if active infection is presentPlain lubricant/antibiotic-only regimensVariesMild post-op cases without significant inflammationMay be insufficient for higher-risk surgical cases\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueReported post-operative infection rate reduction with prophylactic use[Placeholder – insert verified clinical trial statistic]Typical duration of post-cataract-surgery combination therapy[Placeholder – insert verified reference range]Incidence of steroid-induced IOP elevation with short-course use[Placeholder – insert epidemiological reference]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Gatifloxacin and Prednisolone Acetate Ophthalmic Suspension\nThe price of this combination suspension varies depending on brand, pack size, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nGatifloxacin and prednisolone acetate ophthalmic suspension serves an important clinical role wherever bacterial infection risk and ocular inflammation occur together — most notably in the sensitive period following eye surgery. By combining a potent fourth-generation antibiotic with a well-established corticosteroid, this formulation streamlines post-operative and steroid-responsive inflammatory care into a single, clinician-directed regimen. Because the steroid component carries specific long-term risks — including elevated eye pressure, cataract progression, and delayed healing if misused — this medication should always be used exactly as prescribed, for the duration recommended, and with appropriate tapering and follow-up. Patients should never self-adjust dosing or extend use without their ophthalmologist's explicit guidance.\n\nFrequently Asked Questions\n\n1. What is Gatifloxacin and prednisolone acetate ophthalmic suspension used for?\nIt is used to treat eye conditions that involve both inflammation and a risk of bacterial infection — most commonly after eye surgery such as cataract surgery, where it reduces post-operative swelling and redness while protecting against infection.\n\n2. Is Gatifloxacin eye drops safe for children?\nGatifloxacin eye drops are generally considered usable in children for appropriate bacterial eye infections under a pediatric ophthalmologist's guidance. However, the gatifloxacin-prednisolone combination includes a steroid, which requires closer specialist supervision in children due to potential effects on eye pressure and healing, so it should only be used if specifically prescribed for a child.\n\n3. What is Gatifloxacin and prednisolone acetate ophthalmic suspension (Gatiquin P) used for?\nGatiquin P is a branded formulation of gatifloxacin and prednisolone acetate ophthalmic suspension. It is used for the same core purpose — managing post-surgical or steroid-responsive ocular inflammation where there is also a bacterial infection risk, most often following cataract or other intraocular surgery.\n\n4. Is prednisolone acetate safe for eyes?\nPrednisolone acetate is a corticosteroid that is generally safe for eyes when used exactly as prescribed and for the recommended duration under an ophthalmologist's supervision. However, unsupervised or prolonged use can raise intraocular pressure, increase glaucoma risk, contribute to cataract formation, and delay wound healing, so it should never be used without medical guidance or beyond the prescribed course.\n\n5. How is this eye drop different from regular antibiotic eye drops?\nRegular antibiotic eye drops only target bacteria, while this combination also contains a steroid to control inflammation. This dual action is useful specifically when both infection risk and significant inflammation are present, such as after eye surgery.\n\n6. How long should I use gatifloxacin and prednisolone acetate suspension?\nDuration is determined by your ophthalmologist based on your specific condition, often following a tapering schedule after surgery. It should not be used longer than prescribed, and stopping should be discussed with your doctor rather than done abruptly.\n\n7. Can this eye drop increase eye pressure?\nYes, because it contains a steroid, prolonged or unsupervised use can raise intraocular pressure. Regular monitoring is recommended, especially with extended use or in patients with a history of glaucoma.\n\n8. Can I use this suspension for a common bacterial eye infection without inflammation?\nThis combination is generally reserved for cases where both infection risk and notable inflammation are present, such as post-surgical care. For uncomplicated bacterial conjunctivitis without significant inflammation, your doctor may prescribe an antibiotic-only formulation instead.\n\n9. Do I need to shake the bottle before use?\nYes. This is a suspension, so the bottle should be shaken well before each use to ensure even distribution of both active ingredients.\n10. Can this eye drop be used for viral or fungal eye infections?\nNo. This combination is not appropriate for viral, fungal, or mycobacterial eye infections, since it contains a steroid that can worsen these conditions if used inappropriately.\n\n11. What are the signs I should stop using this eye drop and see my doctor?\nIncreasing eye pain, blurred vision that doesn't improve, halos around lights, worsening redness, or signs of an allergic reaction warrant immediate medical attention.\n\n12. Can this eye drop be used after cataract surgery?\nYes, this combination is commonly prescribed after cataract surgery to manage post-operative inflammation while covering the risk of surgical-site infection during the healing period.\n\n13. Does this medication require a prescription?\nYes, gatifloxacin and prednisolone acetate ophthalmic suspension is a prescription-only (Schedule H) medicine and should only be used under an ophthalmologist's direction.\n14. Can contact lenses be worn during treatment?\nIt is generally advised to avoid wearing contact lenses while using this medication unless your ophthalmologist specifically advises otherwise, particularly during the post-surgical period.\n\n15. What happens if I stop this eye drop too early?\nStopping too early, especially without proper tapering, may lead to a rebound of inflammation or leave a lingering infection insufficiently treated. Always follow your doctor's full course and tapering instructions.\n\n16. Is this eye drop safe for long-term daily use?\nNo — because it contains a steroid, it is intended for short-term, supervised use rather than long-term daily use. Extended use significantly raises the risk of elevated eye pressure and cataract.\n\n17. Can this suspension be used in both eyes at once?\nIt can be used in both eyes if both are affected and your doctor has prescribed it for bilateral use; otherwise, apply only to the eye(s) specifically directed by your ophthalmologist.\n",
"price": 155.0,
"discountamount": 47.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2469,
"imageuri": "https://productimages.withfloats.com/actual/6a509bf79c2198e9ddf06962.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a509bf79c2198e9ddf06962.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-10T07:15:02.084Z",
"updatedon": "2026-07-10T07:15:02.084Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//gatifloxacin-prednisolone-acetate-ophthalmic-suspension/2469",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION GATIPRED",
"category": "Opthalmology Range",
"tags": [
"gatifloxacin & prednisolone acetate ophthalmic suspension",
"gatifloxacin & prednisolone ophthalmic suspension"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a460bf90c11f3c74a816c87",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "methylprednisolone sodium succinate for injection usp",
"description": "Methylprednisolone Sodium Succinate for Injection USP is a fast-acting corticosteroid administered intravenously or intramuscularly to control severe inflammation, allergic reactions, and autoimmune flare-ups. It works by rapidly suppressing the immune and inflammatory response and is used in hospital or clinical settings for acute conditions such as severe asthma attacks, anaphylaxis, autoimmune disease flares, and spinal cord injury protocols. It is a Schedule H prescription drug administered only under medical supervision.\n\nWhat Is Methylprednisolone Sodium Succinate for Injection USP?\n\nMethylprednisolone Sodium Succinate for Injection USP is a water-soluble, injectable corticosteroid used for rapid control of severe inflammatory, allergic, and autoimmune conditions. It is manufactured to United States Pharmacopeia (USP) standards and is typically administered by a healthcare professional via intravenous (IV) or intramuscular (IM) route when fast, high-potency anti-inflammatory or immunosuppressive action is required — situations where oral steroids act too slowly or oral intake isn't feasible.\n\nHow It Works\n\nMethylprednisolone sodium succinate is a synthetic glucocorticoid that acts rapidly once reconstituted and injected.\n\n\nBinds glucocorticoid receptors – enters cells and binds intracellular receptors that regulate inflammatory gene expression.\nSuppresses inflammatory mediators – reduces production of prostaglandins, leukotrienes, and cytokines responsible for swelling, redness, and pain.\nStabilizes cell membranes – reduces capillary permeability, limiting fluid leakage and tissue swelling at the site of inflammation.\nDampens immune overactivity – suppresses lymphocyte and macrophage activity, calming autoimmune or allergic overreactions.\nDelivers rapid systemic action – because it's water-soluble and given IV/IM, onset of anti-inflammatory effect is significantly faster than oral steroids.\n\n\nClinical Indications\n\nConditionWhy Methylprednisolone Injection Is UsedSevere Allergic Reactions / AnaphylaxisRapidly controls swelling, airway inflammation, and allergic cascadeAcute Asthma Exacerbation / COPD FlareReduces airway inflammation when inhalers alone are insufficientAutoimmune Disease Flares (Lupus, Rheumatoid Arthritis)High-dose pulse therapy to control acute flaresSpinal Cord Injury (acute, under specialist protocol)Used in specific clinical protocols to limit secondary inflammationSevere Dermatologic ReactionsControls widespread inflammatory skin reactionsPost-Transplant / Organ Rejection ManagementUsed as part of immunosuppressive regimens\n\nDosage & Administration\n\nParameterRecommendationTypical Adult Dose10–40 mg IV, may range up to 30 mg/kg in high-dose pulse therapy for specific conditionsRouteIntravenous (IV) injection/infusion or Intramuscular (IM) injectionFrequencyAs directed by the treating physician; often single dose or short tapering courseReconstitutionMust be reconstituted only with the accompanying diluent as per product insert, immediately before useAdministration SettingHospital, clinic, or under direct medical/nursing supervision onlyDurationShort-term acute use unless otherwise directed; long-term use requires specialist monitoring\n\nThis is a Schedule H prescription-only medicine. Dosage must be determined and administered by a qualified healthcare professional.\n\nPrecautions\n\n\nTo be administered only by or under the supervision of a healthcare professional.\nNot for self-administration or home use.\nInform the doctor of any active infections, as corticosteroids can mask symptoms and suppress immune response.\nUse with caution in patients with diabetes, hypertension, peptic ulcer disease, osteoporosis, or psychiatric history.\nAvoid live vaccines during treatment due to immunosuppressive effects.\nPregnant or breastfeeding patients should use only under strict medical guidance.\nAbrupt discontinuation after prolonged use should be avoided; tapering may be required as advised by the physician.\n\n\nPossible Side Effects\n\nMost side effects relate to the drug's systemic corticosteroid action and are monitored by the administering clinician:\n\n\nElevated blood sugar levels\nFluid retention, increased blood pressure\nMood changes, insomnia, or restlessness\nNausea or gastrointestinal discomfort\nIncreased susceptibility to infection\nInjection site reactions\n\n\nSerious side effects requiring immediate medical attention include severe allergic reaction, signs of infection (fever, chills), significant mood or behavioral changes, unusual swelling, or vision disturbances. Because this is administered in a clinical setting, the healthcare team monitors for these actively.\n\nComparison: Methylprednisolone vs. Other Injectable Corticosteroids\n\nDrugRelative PotencyCommon Use CaseRouteMethylprednisolone Sodium SuccinateHighAcute severe inflammation, autoimmune flaresIV/IMHydrocortisone Sodium SuccinateLowerAdrenal insufficiency, milder acute inflammationIV/IMDexamethasone Sodium PhosphateVery HighCerebral edema, severe allergic/inflammatory conditionsIV/IMBetamethasone Sodium PhosphateHighAllergic and inflammatory conditions, fetal lung maturityIV/IMTriamcinolone AcetonideModerate (depot)Localized/intra-articular inflammationIM/Intra-articular\n\nKey Statistics\n\nStatisticData PointSourceOnset of anti-inflammatory action after IV administrationWithin 1–2 hours for measurable effectClinical pharmacology references, USP monographUse in acute severe asthma protocolsRecommended as part of systemic corticosteroid therapy in emergency guidelinesGlobal Initiative for Asthma (GINA) guidelinesHospital use in anaphylaxis managementIncluded as an adjunct in anaphylaxis treatment protocols alongside epinephrineWorld Allergy Organization guidanceHigh-dose pulse therapy applicationUsed in select autoimmune flare protocols under specialist supervisionPublished rheumatology treatment guidelines\n\nExpert Insight\n\n[Insert verified physician or clinical pharmacologist commentary here — Claude has not fabricated a quote. Recommend sourcing a short, attributable statement from a Steris Healthcare medical advisor or a cited clinical guideline before publishing.]\n\nConclusion\n\nMethylprednisolone Sodium Succinate for Injection USP is a high-potency, fast-acting corticosteroid reserved for situations where rapid control of severe inflammation, allergic reaction, or autoimmune flare is essential. Administered only under clinical supervision, it plays a critical role in emergency and hospital-based treatment protocols — from anaphylaxis and acute asthma to autoimmune disease management. As a Schedule H medicine, it must never be self-administered; dosage, route, and duration should always be determined by a qualified physician based on the patient's condition. For pharmacopoeia-grade quality and reliable hospital supply, source this injection through a WHO-GMP certified manufacturer.\n\nPrescription only – consult your doctor.\n\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n\n1. What is methylprednisolone sodium succinate injection used for?\nIt is used to rapidly control severe inflammation, allergic reactions, and autoimmune flare-ups, such as anaphylaxis, acute asthma attacks, and lupus or rheumatoid arthritis flares. It is administered under medical supervision in hospital or clinical settings.\n\n2. Is methylprednisolone injection a steroid?\nYes, it is a synthetic corticosteroid (glucocorticoid) that works by suppressing inflammatory and immune responses in the body, providing rapid relief in acute, severe conditions.\n\n3. How is methylprednisolone sodium succinate injection given?\nIt is given by a healthcare professional via intravenous (IV) or intramuscular (IM) injection, after being reconstituted with the correct diluent immediately before administration. It is not for self-injection or home use.\n\n4. How fast does methylprednisolone injection start working?\nBecause it is water-soluble and given directly into the bloodstream or muscle, measurable anti-inflammatory effects typically begin within one to two hours of administration.\n\n5. What are the side effects of methylprednisolone injection?\nCommon effects include elevated blood sugar, fluid retention, mood changes, and increased infection risk. These are monitored by the administering healthcare team, and serious reactions are managed promptly in a clinical setting.\n\n6. Is methylprednisolone sodium succinate injection available without a prescription?\nNo. It is a Schedule H prescription-only medicine that must be administered by or under the direct supervision of a qualified healthcare professional.\n\n7. What is the difference between methylprednisolone and dexamethasone injection?\nBoth are injectable corticosteroids, but dexamethasone has a longer duration of action and higher relative potency, while methylprednisolone is often preferred for acute pulse therapy and shorter-acting systemic control. The choice depends on the clinical scenario and physician judgment.\n\n8. Can methylprednisolone injection be used in pregnancy?\nIt may be used in pregnancy only when clearly necessary and under strict medical supervision, as the treating physician will weigh the benefits against potential risks for the specific condition being treated.",
"price": 47.0,
"discountamount": 19.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2465,
"imageuri": "https://productimages.withfloats.com/actual/6a460bfb9f5529389b8b15b8.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a460bfb9f5529389b8b15b8.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-02T06:58:01.631Z",
"updatedon": "2026-07-02T06:58:01.631Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//methylprednisolone-sodium-succinate-for-injection-usp/2465",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "METHIDENOSOLE 40 INJ",
"category": "GENERAL RANGE",
"tags": [
"methylprednisolone sodium succinate injection uses",
"methylprednisolone sodium succinate injection uses in hindi",
"methylprednisolone sodium succinate",
"methylprednisolone sodium succinate injection",
"inj methylprednisolone sodium succinate",
"methylprednisolone sodium succinate uses in hindi",
"methylprednisolone sodium succinate for injection",
"methylprednisolone sodium succinate injection usp"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a4266621f2199a803b27013",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "luliconazole lotion ip 1% w/v",
"description": "Luliconazole Lotion IP 1% w/v\n\nTL;DR: Luliconazole Lotion IP 1% w/v is a topical antifungal treatment used to treat fungal skin infections such as ringworm (tinea corporis), athlete's foot (tinea pedis), and jock itch (tinea cruris). It works by destroying the fungal cell membrane, typically showing improvement within 1–2 weeks of consistent use. Lightweight and fast-absorbing, it's applied once daily to the affected area for effective relief from itching, redness, and scaling. Check uses, price, dosage & side effects below before you buy.\n\nWhat Is Luliconazole Lotion IP 1% w/v?\n\nLuliconazole Lotion IP 1% w/v is a topical antifungal medication belonging to the azole class, formulated specifically to treat superficial fungal infections of the skin. Unlike traditional antifungal creams, the lotion base allows for quicker absorption and easier application over larger or hairier areas of the body, making it a practical choice for body fold infections and broader patches of skin involvement.\n\nIt is commonly prescribed or recommended for dermatophyte infections — fungal infections caused by organisms that thrive on keratin in skin, hair, and nails — including ringworm, athlete's foot, and jock itch. Its once-daily dosing schedule and relatively short treatment duration compared to older antifungals make it a convenient option for both short-term flare-ups and recurring fungal skin conditions.\n\nHow It Works (Mechanism of Action)\n\nC – Clarity: Luliconazole inhibits the enzyme lanosterol 14-alpha-demethylase, a key enzyme fungi need to produce ergosterol, an essential component of the fungal cell membrane.\n\nR – Relevance: Without sufficient ergosterol, the fungal cell membrane becomes structurally unstable and permeable, directly disrupting the fungus's ability to survive and multiply on the skin — which is precisely the mechanism needed to clear dermatophyte infections like ringworm and athlete's foot.\n\nA – Authority: Luliconazole's potency against common dermatophytes, including Trichophyton and Epidermophyton species, is well documented in dermatology literature, where it is recognized for its fungicidal (not just fungistatic) activity at the concentrations used in topical formulations.\n\nS – Structure: When applied topically, luliconazole penetrates the stratum corneum (the skin's outer layer) and accumulates at the site of infection, maintaining therapeutic concentrations in the skin for an extended period even after a single application, which supports its once-daily dosing.\n\nP – Precision: This sustained local concentration allows luliconazole to continue disrupting fungal cell membranes throughout the day, leading to a reduction in itching, redness, and scaling as the fungal load decreases and the skin barrier begins to heal.\n\nClinical Indications / Who Should Use It\n\nIndicationSuitabilityTinea corporis (ringworm on the body)Highly suitableTinea pedis (athlete's foot)Highly suitableTinea cruris (jock itch)Highly suitableRecurrent superficial fungal skin infectionsSuitableNail fungus (onychomycosis)Not suitable — requires different formulationPregnant or breastfeeding womenConsult doctor before use\n\nDosage Guidelines\n\nParameterRecommendationStandard applicationApply a thin layer once daily to the affected area and surrounding skinApplication areaClean and dry the skin before applicationCourse durationTypically 1–2 weeks for tinea corporis/cruris; up to 4 weeks for tinea pedisConsistencyContinue for the full prescribed duration even if symptoms improve earlyMissed applicationApply as soon as remembered; do not double up the next dose\n\nPrecautions & Drug Interactions\n\n\nFor external use only — avoid contact with eyes, mouth, nose, or open wounds.\nDiscontinue use and consult a doctor if irritation, burning, or worsening of symptoms occurs after application.\nAvoid using occlusive dressings or tight clothing over the treated area unless advised by a doctor, as this may increase skin irritation.\nInform your doctor if you are using other topical medications on the same area, to avoid interactions or reduced effectiveness.\nNot recommended for infections involving the scalp or nails, which often require oral antifungal therapy in addition to or instead of topical treatment.\nIf no improvement is seen after the recommended treatment duration, consult a doctor to reassess the diagnosis and treatment plan.\n\n\nSerious Side Effects (Rare but Important)\n\n\nSevere allergic reaction — swelling of the face or throat, difficulty breathing, or widespread rash\nPersistent burning, stinging, or blistering at the application site\nSigns of secondary skin infection, such as increasing redness, warmth, or pus\n\n\nIf any of these occur, discontinue use and seek medical attention promptly.\n\nComparison: Luliconazole vs Other Topical Antifungals\n\nFactorLuliconazole 1%ClotrimazoleTerbinafineKetoconazoleDosing frequencyOnce dailyTwice dailyOnce/twice dailyOnce/twice dailyMechanismFungicidal (azole)Fungistatic (azole)Fungicidal (allylamine)Fungistatic (azole)Typical treatment duration1–2 weeks (body), up to 4 weeks (feet)2–4 weeks1–2 weeks2–4 weeksBest forTinea corporis, cruris, pedisMild fungal infectionsAthlete's footTinea, seborrheic conditions\n\nKey Statistics\n\nMetricData PointStrength1% w/v luliconazoleDrug classAzole antifungal (topical)Typical onset of symptom reliefWithin 1–2 weeks of consistent useRecommended application frequencyOnce daily\n\nExpert Insight\n\n[Placeholder — to be completed pre-publish with a quote or review from a certified dermatologist. Do not publish without expert validation.]\n\nWhy Choose Luliconazole Lotion IP 1% w/v?\n\nFungal skin infections are common in humid climates and tend to recur, particularly in areas prone to sweating and friction such as the groin, feet, and skin folds. Luliconazole's fungicidal action — meaning it actively kills the fungus rather than just slowing its growth — gives it an edge over some older antifungal agents that are primarily fungistatic and rely more heavily on the body's own immune response to fully clear the infection.\n\nThe lotion formulation is particularly well-suited to larger affected areas or body folds, where creams can sometimes feel heavy or difficult to spread evenly. Its lightweight texture absorbs quickly, making it comfortable for daily use without leaving a greasy residue, which also supports better adherence to the treatment course — a key factor in successfully clearing fungal infections and reducing recurrence.\n\nBecause of its once-daily dosing and relatively short treatment duration compared to many alternatives, luliconazole lotion is often preferred by people looking for a convenient yet effective option for ringworm, athlete's foot, or jock itch, especially when consistent twice-daily application of other antifungals proves difficult to maintain.\n\nFrequently Asked Questions\n\nQ1: How long does it take for Luliconazole Lotion to work?\nMost people notice a reduction in itching, redness, and scaling within 1–2 weeks of consistent daily application. For tinea corporis and tinea cruris, treatment typically lasts 1–2 weeks, while tinea pedis (athlete's foot) may require up to 4 weeks for complete resolution. It's important to continue treatment for the full recommended duration even if symptoms improve earlier.\n\nQ2: How should I apply Luliconazole Lotion correctly?\nClean and dry the affected area thoroughly before applying a thin layer of the lotion, covering the infected skin and a small margin of surrounding healthy skin. Apply once daily, ideally at the same time each day, and wash your hands after application unless the hands are the area being treated.\n\nQ3: Can Luliconazole Lotion be used for athlete's foot?\nYes, Luliconazole Lotion is effective for tinea pedis (athlete's foot), though treatment duration is typically longer than for body or groin infections — often up to 4 weeks — due to the thicker skin and moist environment common on the feet, which can make fungal infections more persistent.\n\nQ4: Does Luliconazole Lotion have side effects?\nMost people tolerate it well with minimal side effects. Mild burning, stinging, or redness at the application site can occur but usually resolves on its own. Rare but serious reactions, such as severe allergic responses or blistering, should be reported to a doctor immediately if they occur.\n\nQ5: Can Luliconazole Lotion be used on the face or scalp?\nLuliconazole Lotion is generally formulated for body, groin, and foot fungal infections. Scalp fungal infections often require oral antifungal treatment alongside topical therapy, so it's best to consult a doctor before using it on the scalp or sensitive facial skin.\n\nQ6: What happens if I stop using Luliconazole Lotion too early?\nStopping treatment as soon as symptoms improve, rather than completing the full recommended course, increases the risk of the fungal infection returning or becoming harder to treat. Even after visible symptoms clear, some fungal organisms may remain in the skin, so completing the full duration is important for lasting results.\n\n\nThis content is reviewed periodically to ensure accuracy and relevance. Last updated: June 2026.\n\nFor queries, contact Steris Healthcare:\n📧 contact@sterispharma.com | info@sterispharma.com\n📞 +91 8824175417 | +91 9982524671",
"price": 580.0,
"discountamount": 174.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2461,
"imageuri": "https://productimages.withfloats.com/actual/6a4266662d3bce0a42051cc2.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a4266662d3bce0a42051cc2.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-06-29T12:34:42.967Z",
"updatedon": "2026-06-29T12:34:42.967Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//luliconazole-lotion-ip-1-w-v/2461",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "LONICAZOLE LOTION",
"category": "DERMATALOGY",
"tags": [
"luliconazole lotion ip 1% w/v",
"luliconazole lotion",
"luliconazole lotion uses",
"luliconazole lotion uses in hindi",
"luliconazole lotion 1 w/v",
"luliconazole lotion ip uses in hindi",
"luliconazole lotion ip",
"luliconazole lotion ip 1 w/v",
"luliconazole lotion price",
"luliconazole lotion ip 1 w/v uses in hindi"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}